← All trials
NCT04695080
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2021
- Primary completion
- Jul 4, 2024
- Completion date
- Jul 4, 2024
- First posted
- Jan 5, 2021
- Last posted
- Mar 11, 2021
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LondonLead sponsor
- University of LondonCollaborator
- University of LeedsCollaborator
- University of LeedsCollaborator
- University of EdinburghCollaborator
- University of PlymouthCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.